• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary].

作者信息

Kidera Y, Yoshimura T, Ohkuma Y, Iwasaka T, Sugimori H

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1985 Sep;37(9):1820-4.

PMID:4056530
Abstract

A human tumor cell line MCAS, which was derived from mucinous cystadenocarcinoma of the ovary, was established. The tissue specimen was obtained on December 1, 1983 and the culture was maintained in Ham's F-12 medium supplemented with 20% fetal calf serum. Continuous growth made possible cell transfer every 3-5 days and the seventy-third passage was achieved on August 15, 1984. This cell line has the following characteristics. The doubling time of the MCAS cell line was 27 hours and the saturation density was 5.1 X 10(4)/cm2. The cultured cells appeared monolayer and the cellular arrangement was a pavement-like pattern. Rather large cells with vacuoles in the cytoplasm appeared in the confluent state and PAS staining proved to be positive specifically in these large cells. A chromosomal analysis revealed a peritetraploid tendency. By heterotransplantation of MCAS cells to the nude athymic mouse, the tumor developed and had both cystic and solid components. The cystic content was mucinous. Histopathological diagnosis of the tumor was papillary adenocarcinoma and alcian blue staining was positive. The characteristics of the original mucinous cystadenocarcinoma have been precisely maintained in this cell line.

摘要

相似文献

1
[Establishment and characterization of a cell line derived from mucinous cystadenocarcinoma of human ovary].
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Sep;37(9):1820-4.
2
Establishment and characterization of a new human cell-line (AMOC-2) derived from a serous adenocarcinoma of ovary.源自卵巢浆液性腺癌的新型人类细胞系(AMOC-2)的建立与鉴定
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Jul;41(7):888-94.
3
A newly established cel line derived from human ovarian adenocarcinoma.一种新建立的源自人卵巢腺癌的细胞系。
Jpn J Exp Med. 1980 Aug;50(4):283-92.
4
Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.源自人卵巢浆液性囊腺癌的新建立细胞系HUOA的特性分析
Nihon Sanka Fujinka Gakkai Zasshi. 1987 May;39(5):831-6.
5
Characterization of a human ovarian carcinoma cell line: UCI 101.一种人卵巢癌细胞系UCI 101的特性分析。
Gynecol Oncol. 1993 Feb;48(2):203-9. doi: 10.1006/gyno.1993.1034.
6
[Establishment and characterization of the cell line derived from low differentiated adenocarcinoma of the endometrium].[子宫内膜低分化腺癌来源细胞系的建立与鉴定]
Hokkaido Igaku Zasshi. 1986 Jul;61(4):599-604.
7
[Biological properties of two newly established cell lines (RMUG-S, RMUG-L) from a human ovarian mucinous cystadenocarcinoma].
Hum Cell. 1990 Mar;3(1):52-6.
8
[Establishment and characterization of a cell line derived from human ovarian mucinous cystadenocarcinoma].[人卵巢黏液性囊腺癌来源细胞系的建立与鉴定]
Zhonghua Fu Chan Ke Za Zhi. 2001 Jul;36(7):421-3.
9
[Establishment and characterization of human ovarian endometrioid carcinoma cell line].
Nihon Sanka Fujinka Gakkai Zasshi. 1989 Feb;41(2):161-6.
10
Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary.源自一名卵巢乳头状浆液性囊腺癌患者腹水的细胞系的特征分析。
J Natl Cancer Inst. 1984 Mar;72(3):513-21.

引用本文的文献

1
Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas.罕见的上皮性卵巢癌:低级别浆液性和黏液性癌。
Cold Spring Harb Perspect Med. 2023 Sep 1;13(9):a038190. doi: 10.1101/cshperspect.a038190.
2
Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine.卵巢癌的三维建模:从细胞系到类器官用于发现和个性化医疗
Front Bioeng Biotechnol. 2022 Feb 10;10:836984. doi: 10.3389/fbioe.2022.836984. eCollection 2022.
3
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.
卵巢癌细胞系的综合基因组、表观基因组和表达分析。
Cell Rep. 2018 Nov 27;25(9):2617-2633. doi: 10.1016/j.celrep.2018.10.096.
4
Functional role of the Tau protein in epithelial ovarian cancer cells.Tau蛋白在上皮性卵巢癌细胞中的功能作用。
Reprod Med Biol. 2017 Mar 20;16(2):143-151. doi: 10.1002/rmb2.12019. eCollection 2017 Apr.
5
Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.表皮生长因子调节卵巢癌细胞系中的 Claudin 蛋白和紧密连接功能。
Histochem Cell Biol. 2012 Aug;138(2):323-38. doi: 10.1007/s00418-012-0956-x. Epub 2012 Apr 29.
6
SNOSite: exploiting maximal dependence decomposition to identify cysteine S-nitrosylation with substrate site specificity.SNOSite:利用最大依赖分解鉴定具有底物特异性的半胱氨酸 S-亚硝酰化。
PLoS One. 2011;6(7):e21849. doi: 10.1371/journal.pone.0021849. Epub 2011 Jul 15.
7
Correlation between expression of oncogene products and resistance to anticancer drugs in cultured ovarian cancer cell lines.培养的卵巢癌细胞系中癌基因产物表达与抗癌药物耐药性之间的相关性。
Hum Cell. 2003 Sep;16(3):131-9. doi: 10.1111/j.1749-0774.2003.tb00145.x.
8
Establishment and characterization of a cell-line originated from human mucinous cystadenocarcinoma of the ovary.源自人卵巢黏液性囊腺癌的细胞系的建立与鉴定
Hum Cell. 2002 Sep;15(3):171-7. doi: 10.1111/j.1749-0774.2002.tb00111.x.
9
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Arch Gynecol Obstet. 1988;243(2):69-81. doi: 10.1007/BF00932972.